Portfolio Company News

November 6, 2025

Synchron raises $200M Series D to support BCI commercialization, next-gen tech

October 9, 2025

Synchron Stentrode

October 7, 2025

Tulavi Therapeutics Expands Indication for allay™ Hydrogel Cap to Smaller Patients, 25 kg and Above

August 26, 2025

Tulavi Therapeutics Selected to Exhibit the allay™ Hydrogel Cap at Vizient Innovative Technology Exchange

August 10, 2025

Synchron vs. Neuralink: BCI Brain Implants Compared

July 23, 2025

Tulavi and VHSS Partner to Bring Groundbreaking Surgical Nerve Treatment to Veterans Impacted by Amputations and Traumatic Injuries

July 14, 2025

Borvo EVAC™ System Demonstrates 100% Success Rate in Chronic Subdural Hematoma Clinical Cases Validated Across 5 Medical Centers

July 10, 2025

Radical Catheter Technologies’ 8F Neurovascular Guide Catheter Demonstrates Outstanding Clinical Performance in Initial Cases

May 13, 2025

Synchron To Achieve First Native Brain-Computer Interface Integration with iPhone, iPad and Apple Vision Pro

April 8, 2025

Kandu Health and Neurolutions Merge to Form Kandu, Inc., a New Leader in Stroke Recovery

March 19, 2025

Synchron Unveils Chiral™, the World’s First Cognitive AI Brain Foundation Model

March 19, 2025

Synchron’s Brain-Computer Interface Now Has Nvidia’s AI